17-12917329-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_014859.6(ARHGAP44):c.387+1318G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 153,760 control chromosomes in the GnomAD database, including 6,805 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.23 ( 6790 hom., cov: 32)
Exomes 𝑓: 0.11 ( 15 hom. )
Consequence
ARHGAP44
NM_014859.6 intron
NM_014859.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.379
Publications
13 publications found
Genes affected
ARHGAP44 (HGNC:29096): (Rho GTPase activating protein 44) Enables phospholipid binding activity. Predicted to be involved in several processes, including modification of dendritic spine; negative regulation of Rac protein signal transduction; and regulation of plasma membrane bounded cell projection organization. Located in leading edge membrane. [provided by Alliance of Genome Resources, Apr 2022]
MIR1269B (HGNC:41787): (microRNA 1269b) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.511 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.225 AC: 34243AN: 151984Hom.: 6769 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
34243
AN:
151984
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0824 AC: 30AN: 364 AF XY: 0.0750 show subpopulations
GnomAD2 exomes
AF:
AC:
30
AN:
364
AF XY:
Gnomad AFR exome
AF:
Gnomad EAS exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.107 AC: 178AN: 1658Hom.: 15 Cov.: 0 AF XY: 0.109 AC XY: 103AN XY: 948 show subpopulations
GnomAD4 exome
AF:
AC:
178
AN:
1658
Hom.:
Cov.:
0
AF XY:
AC XY:
103
AN XY:
948
show subpopulations
African (AFR)
AF:
AC:
22
AN:
60
American (AMR)
AF:
AC:
4
AN:
14
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
6
East Asian (EAS)
AF:
AC:
9
AN:
18
South Asian (SAS)
AF:
AC:
12
AN:
44
European-Finnish (FIN)
AF:
AC:
0
AN:
4
Middle Eastern (MID)
AF:
AC:
71
AN:
772
European-Non Finnish (NFE)
AF:
AC:
39
AN:
610
Other (OTH)
AF:
AC:
21
AN:
130
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.226 AC: 34305AN: 152102Hom.: 6790 Cov.: 32 AF XY: 0.227 AC XY: 16865AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
34305
AN:
152102
Hom.:
Cov.:
32
AF XY:
AC XY:
16865
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
21424
AN:
41468
American (AMR)
AF:
AC:
2382
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
574
AN:
3470
East Asian (EAS)
AF:
AC:
2218
AN:
5146
South Asian (SAS)
AF:
AC:
1424
AN:
4818
European-Finnish (FIN)
AF:
AC:
878
AN:
10584
Middle Eastern (MID)
AF:
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4983
AN:
68020
Other (OTH)
AF:
AC:
387
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1065
2131
3196
4262
5327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
318
636
954
1272
1590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1226
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.